US 10946033
2′-substituted-N6-substituted purine nucleotides for RNA virus treatment
granted A61KA61K31/675A61K31/7076
Quick answer
US patent 10946033 (2′-substituted-N6-substituted purine nucleotides for RNA virus treatment) held by Atea Pharmaceuticals, Inc. expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Atea Pharmaceuticals, Inc.
- Grant date
- Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/675, A61K31/7076, A61P, A61P1/00